אסופרים אס.קיי. 40 מג Israel - ebraică - Ministry of Health

אסופרים אס.קיי. 40 מג

k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - קפסולה קשיחה - esomeprazole as sodium 40 mg - esomeprazole

סולזול Israel - ebraică - Ministry of Health

סולזול

k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole

אסופרים קונטרול 20 מג Israel - ebraică - Ministry of Health

אסופרים קונטרול 20 מג

k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - קפסולה קשיחה - esomeprazole as sodium 20 mg - esomeprazole

אזומפרזול מדי מרקט 40 מג Israel - ebraică - Ministry of Health

אזומפרזול מדי מרקט 40 מג

a.l. medi-market ltd. - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole

וימובו Israel - ebraică - Ministry of Health

וימובו

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers.vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

וימובו Israel - ebraică - Ministry of Health

וימובו

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers. vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

וימובו Israel - ebraică - Ministry of Health

וימובו

astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers. vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

הרווני Israel - ebraică - Ministry of Health

הרווני

gilead sciences israel ltd - ledipasvir; sofosbuvir - טבליות מצופות פילם - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir

הרווני Israel - ebraică - Ministry of Health

הרווני

gilead sciences israel ltd - ledipasvir; sofosbuvir - טבליות מצופות פילם - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir

הרווני Israel - ebraică - Ministry of Health

הרווני

gilead sciences israel ltd - ledipasvir; sofosbuvir - טבליות מצופות פילם - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir